| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.42B | 14.19B | 14.27B | 14.00B | 15.48B | 35.71B |
| Gross Profit | 6.17B | 6.17B | 6.70B | 6.28B | 6.90B | 8.07B |
| EBITDA | -439.78M | -759.40M | 393.34M | 856.45M | 1.50B | 2.44B |
| Net Income | -404.53M | -530.40M | 1.01B | 254.88M | 310.44M | 1.43B |
Balance Sheet | ||||||
| Total Assets | 28.61B | 29.53B | 27.08B | 25.41B | 25.09B | 27.07B |
| Cash, Cash Equivalents and Short-Term Investments | 8.93B | 10.10B | 12.86B | 14.31B | 13.77B | 17.97B |
| Total Debt | 16.49B | 17.11B | 11.88B | 10.75B | 11.10B | 11.92B |
| Total Liabilities | 19.44B | 20.20B | 16.28B | 15.44B | 15.44B | 17.33B |
| Stockholders Equity | 9.05B | 9.20B | 10.66B | 9.80B | 9.39B | 9.21B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -835.03M | 187.66M | 1.66B | 941.22M | 2.24B |
| Operating Cash Flow | 0.00 | -776.06M | 222.82M | 1.67B | 1.16B | 2.33B |
| Investing Cash Flow | 0.00 | -6.59B | -2.24B | -776.76M | -1.47B | -36.80M |
| Financing Cash Flow | 0.00 | 4.63B | 563.50M | -354.12M | -692.96M | -1.29B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥33.96B | 20.10 | ― | ― | 27.97% | -5.25% | |
70 Outperform | ¥40.78B | 17.94 | ― | ― | ― | ― | |
68 Neutral | ¥23.68B | 15.25 | ― | ― | 14.28% | -30.60% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
51 Neutral | ¥5.96B | -8.89 | ― | ― | -12.37% | 12.44% | |
49 Neutral | ¥26.49B | 39.28 | ― | ― | 20.84% | 10.41% | |
48 Neutral | ¥12.55B | 30.14 | ― | 3.48% | -11.85% | ― |